Shagun Singh
Stock Analyst at RBC Capital
(2.39)
# 2,512
Out of 4,905 analysts
211
Total ratings
52.22%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Outperform | $181 → $185 | $163.70 | +13.01% | 22 | Jul 17, 2025 | |
| ZYXI Zynex | Maintains: Sector Perform | $4 → $3 | $2.31 | +29.87% | 8 | Jul 15, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $145 → $130 | $111.06 | +17.05% | 21 | Jul 15, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $145 → $147 | $123.67 | +18.86% | 14 | Jul 15, 2025 | |
| MDT Medtronic | Maintains: Outperform | $105 → $101 | $89.61 | +12.71% | 21 | May 22, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $14 → $21 | $17.35 | +21.04% | 11 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $125 → $112 | $93.19 | +20.18% | 14 | May 6, 2025 | |
| PEN Penumbra | Maintains: Outperform | $315 → $330 | $230.38 | +43.24% | 14 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $116 → $120 | $103.64 | +15.79% | 15 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $630 → $605 | $518.62 | +16.66% | 14 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $215 | $126.84 | +69.50% | 5 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $340 | $284.23 | +19.62% | 1 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $55 | $14.77 | +272.38% | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $76.49 | +11.13% | 21 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $389.40 | +11.71% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $56.34 | +63.29% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $83.89 | +37.08% | 4 | Oct 25, 2024 |
Johnson & Johnson
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $163.70
Upside: +13.01%
Zynex
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $2.31
Upside: +29.87%
Teleflex
Jul 15, 2025
Maintains: Sector Perform
Price Target: $145 → $130
Current: $111.06
Upside: +17.05%
Abbott Laboratories
Jul 15, 2025
Maintains: Outperform
Price Target: $145 → $147
Current: $123.67
Upside: +18.86%
Medtronic
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $89.61
Upside: +12.71%
Outset Medical
May 21, 2025
Maintains: Sector Perform
Price Target: $14 → $21
Current: $17.35
Upside: +21.04%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $125 → $112
Current: $93.19
Upside: +20.18%
Penumbra
Apr 24, 2025
Maintains: Outperform
Price Target: $315 → $330
Current: $230.38
Upside: +43.24%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $103.64
Upside: +15.79%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $630 → $605
Current: $518.62
Upside: +16.66%
Apr 15, 2025
Maintains: Outperform
Price Target: $260 → $215
Current: $126.84
Upside: +69.50%
Mar 6, 2025
Initiates: Outperform
Price Target: $340
Current: $284.23
Upside: +19.62%
Feb 27, 2025
Maintains: Outperform
Price Target: $65 → $55
Current: $14.77
Upside: +272.38%
Feb 12, 2025
Reiterates: Outperform
Price Target: $85
Current: $76.49
Upside: +11.13%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $389.40
Upside: +11.71%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $56.34
Upside: +63.29%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $83.89
Upside: +37.08%